[1. David SH. Diabetic cardiomyopathy. Dibetes Care. 2003; 26:2949-51.10.2337/diacare.26.10.294914514607]Search in Google Scholar
[2. Xu CS, Li ZL, Xue SR. The variation trend of plasma adrenomedullin levels in rats with diabetic cardiomyopathy and its significance. Guangdong Medical Journal. 2005; 7:901-3.]Search in Google Scholar
[3. Acosta J, Hettinga J, Fluckiger R, Krumrei N, Goldfine A, Angarita L, et al. Molecular basis for a link bewteen complement and the vascular complications of diabetes. Pro Natl Acad Sci USA. 2000; 97:5450-5.10.1073/pnas.97.10.54502584910805801]Open DOISearch in Google Scholar
[4. Davies CS, Harris CL, Morgan BP. Glycation of CD59 impairs complement regulation on erythrocytes from dibetic sbujects. Immunology. 2005; 114:280-6.10.1111/j.1365-2567.2004.02086.x178207015667573]Open DOISearch in Google Scholar
[5. Turk Z, Sesto M, Skodlar J, Ferencak G, Turk N, Stavljeniæ-Rukavina A. Soluble LDL-immune complexes in type 2 diabetes and vascular disease. Horm Metab Res. 2002; 34:196-201.10.1055/s-2002-2670611987029]Search in Google Scholar
[6. Granberg V, Ejskjaer N, Peakman M, et al. Autoantibodies to autonomic nerves associated with cardiac and peripheral autonomic neuropathy. Diabetes Care. 2005; 28:1959-64.10.2337/diacare.28.8.195916043739]Open DOISearch in Google Scholar